Skip to main content Accessibility help

Cardiovascular benefits of lycopene: fantasy or reality?

  • Frank Thies (a1), Lynsey M. Mills (a1), Susan Moir (a1) and Lindsey F. Masson (a2)


Epidemiological evidence indicates that high consumption of tomatoes and tomato-based products reduces the risk of chronic diseases such as CVD and cancer. Such potential benefits are often ascribed to high concentrations of lycopene present in tomato products. Mainly from the results of in vitro studies, potential biological mechanisms by which carotenoids could protect against heart disease and cancer have been suggested. These include cholesterol reduction, inhibition of oxidation processes, modulation of inflammatory markers, enhanced intercellular communication, inhibition of tumourigenesis and induction of apoptosis, metabolism to retinoids and antiangiogenic effects. However, with regard to CVD, results from intervention studies gave mixed results. Over fifty human intervention trials with lycopene supplements or tomato-based products have been conducted to date, the majority being underpowered. Many showed some beneficial effects but mostly on non-established cardiovascular risk markers such as lipid peroxidation, DNA oxidative damage, platelet activation and inflammatory markers. Only a few studies showed improvement in lipid profiles, C reactive protein and blood pressure. However, recent findings indicate that lycopene could exert cardiovascular protection by lowering HDL-associated inflammation, as well as by modulating HDL functionality towards an antiatherogenic phenotype. Furthermore, in vitro studies indicate that lycopene could modulate T lymphocyte activity, which would also inhibit atherogenic processes and confer cardiovascular protection. These findings also suggest that HDL functionality deserves further consideration as a potential early marker for CVD risk, modifiable by dietary factors such as lycopene.

  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the or variations. ‘’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Cardiovascular benefits of lycopene: fantasy or reality?
      Available formats

      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Cardiovascular benefits of lycopene: fantasy or reality?
      Available formats

      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Cardiovascular benefits of lycopene: fantasy or reality?
      Available formats


Corresponding author

* Corresponding author: F. Thies, email


Hide All
1. Trichopoulou, A, Costacou, T, Bamia, C et al. (2003) Adherence to a Mediterranean diet and survival in a Greek population. N Engl J Med 348, 25992608.
2. Agudo, A, Cabrera, L, Amiano, P et al. (2007) Fruit and vegetable intakes, dietary antioxidant nutrients, and total mortality in Spanish adults: findings from the Spanish cohort of the European Prospective Investigation into Cancer and Nutrition (EPIC-Spain). Am J Clin Nutr 85, 16341642.
3. Nicklett, EJ, Semba, RD, Xue, QL et al. (2012) Fruit and vegetable intake, physical activity, and mortality in older community dwelling women. J Am Geriatr Soc 60, 862868.
4. Wang, X, Ouyang, Y, Liu, J et al. (2014) Fruit and vegetable consumption and mortality from all causes, cardiovascular disease, and cancer: systematic review and dose-response meta-analysis of prospective cohort studies. BMJ 349, g4490.
5. Maiani, G, Casto´n, MJ, Catasta, G et al. (2009) Carotenoids: actual knowledge on food sources, intakes, stability and bioavailability and their protective role in humans. Mol Nutr Food Res 53, Suppl. 2, S194S218.
6. Zu, K, Mucci, L, Rosner, BA et al. (2014) Dietary lycopene, angiogenesis, and prostate cancer: a prospective study in the prostate-specific antigen era. J Natl Cancer Inst 106, djt430.
7. Giovannucci, E, Ascherio, A, Rimm, EB et al. (1995) Intake of carotenoids and retinol in relation to risk of prostate cancer. J Natl Cancer Inst 87, 17671776.
8. Giovannucci, E, Rimm, EB, Liu, Y et al. (2002) A prospective study of tomato products, lycopene, and prostate cancer risk. J Natl Cancer Inst 94, 391398.
9. Sesso, HD, Liu, S, Gaziano, JM et al. (2003) Dietary lycopene, tomato-based food products and cardiovascular disease in women. J Nutr 133, 23362341.
10. Clinton, SK (1998) Lycopene: chemistry, biology, and implications for human health and disease. Nutr Rev 56, 3551.
11. Rao, AV, Ray, MR & Rao, LG (2006) Lycopene. Adv Food Nutr Res 51, 99164.
12. Ganji, V & Kafai, MR (2005) Population determinants of serum lycopene concentrations in the United States: data from the Third National Health and Nutrition Examination Survey, 1988–1994. J Nutr 135, 567572.
13. Allen, CM, Schwartz, SJ, Craft, NE et al. (2003) Changes in plasma and oral mucosal lycopene isomer concentrations in healthy adults consuming standard servings of processed tomato products. Nutr Cancer 47, 4856.
14. Re, R, Mishra, GD, Thane, CW et al. (2003) Tomato consumption and plasma lycopene concentration in people aged 65 y and over in a British national survey. Eur J Clin Nutr 57, 15451554.
15. Erdman, JW Jr, Ford, NA & Lindshield, BL (2009) Are the health attributes of lycopene related to its antioxidant function? Arch Biochem Biophys 483, 229235.
16. Jenab, M, Ferrari, P, Mazuir, M et al. (2005) Variations in lycopene blood levels and tomato consumption across European countries based on the European Prospective Investigation into Cancer and Nutrition (EPIC) study. J Nutr 135, 2032S2036S.
17. Friedman, M (2013) Anticarcinogenic, cardioprotective, and other health benefits of tomato compounds lycopene, α-tomatine, and tomatidine in pure form and in fresh and processed tomatoes. J Agric Food Chem 61, 95349550.
18. Di Mascio, P, Kaiser, S & Sies, H (1989) Lycopene as the most efficient biological carotenoid singlet oxygen quencher. Arch Biochem Biophys 274, 532538.
19. Pennathur, S, Maitra, D, Byun, J et al. (2010) Antioxidative activity of lycopene: a potential role in scavenging hypochlorous acid. Free Radic Biol Med 49, 205213.
20. Porrini, M & Riso, P (2005) What are typical lycopene intakes? J Nutr 135, 2042S2045S.
21. Thies, F, Masson, LF, Rudd, A et al. (2012) Effect of a tomato-rich diet on markers of cardiovascular disease risk in moderately overweight, disease-free, middle-aged adults: a randomized controlled trial. Am J Clin Nutr 102, 14361449.
22. Jacques, PF, Lyass, A, Massaro, JM et al. (2013) relation of lycopene intake and consumption of tomato products to incident cardiovascular disease. Br J Nutr 110, 545551.
23. Lucarini, M, Lanzi, S, D'Evoli, L et al. (2006) Intake of vitamin A and carotenoids from the Italian population–results of an Italian total diet study. Int J Vitam Nutr Res 76, 103109.
24. Schierle, J, Bretzel, W, Buhler, I et al. (1997) Content and isomeric ratio of lycopene in food and human blood plasma. Food Chem 59, 459465.
25. Walfisch, Y, Walfisch, S, Agbaria, R et al. (2003) Lycopene in serum, skin and adipose tissues after tomato-oleoresin supplementation in patients undergoing haemorrhoidectomy or peri-anal fistulotomy. Br J Nutr 90, 759766.
26. Burton-Freeman, BM & Sesso, HD (2014) Whole food versus supplement: comparing the clinical evidence of tomato intake and lycopene supplementation on cardiovascular risk factors. Adv Nutr 5, 457485.
27. Re, R, Fraser, PD, Long, M et al. (2001) Isomerization of lycopene in the gastric milieu. Biochem Biophys Res Commun 281, 576578.
28. Richelle, M, Sanchez, B, Tavazzi, I et al. (2010) Lycopene isomerisation takes place within enterocytes during absorption in human subjects. Br J Nutr 10, 18001807.
29. Teodoro, AJ, Perrone, D, Martucci, RB et al. (2009) Lycopene isomerisation and storage in an in vitro model of murine hepatic stellate cells. Eur J Nutr 48, 261268.
30. Moussa, M, Landrier, JF, Reboul, E et al. (2008) Lycopene absorption in human intestinal cells and in mice involves scavenger receptor class B type I but not Niemann–Pick C1-like 1. J Nutr 138, 14321436.
31. Moussa, M, Gouranton, E, Gleize, B et al. (2011) CD36 is involved in lycopene and lutein uptake by adipocytes and adipose tissue cultures. Mol Nutr Food Res 55, 578584.
32. Ferrucci, L, Perry, JR, Matteini, A et al. (2009) Common variation in the beta-carotene 15,15′ monooxygenase 1 gene affects circulating levels of carotenoids: a genome-wide association study. Am J Hum Genet 84, 123133.
33. Lindshield, BL, Canene-Adams, K & Erdman, JW Jr (2007) Lycopenoids: are lycopene metabolites bioactive? Arch Biochem Biophys 458, 136140.
34. Ross, AB, Vuong le, T, Ruckle, J et al. (2011) Lycopene bioavailability and metabolism in humans: an accelerator mass spectrometry study. Am J Clin Nutr 93, 12631273.
35. Moran, NE, Cichon, MJ, Riedl, KM et al. (2015) Compartmental and noncompartmental modelling of 13C-lycopene absorption, isomerization and distribution kinetics in healthy adults. Am J Clin Nutr 102, 14361449.
36. Rock, CL, Swendseid, ME, Jacob, RA et al. (1992) Plasma carotenoid levels in human subjects fed a low carotenoid diet. J Nutr 122, 96100.
37. Borel, P, Desmarchelier, C, Nowicki, M et al. (2015) Lycopene bioavailability is associated with a combination of genetic variants. Free Rad Biol Med 83, 238244.
38. Zubair, N, Kooperberg, C, Liu, J et al. (2015) Genetic variation predicts serum lycopene concentrations in a multiethnic population of postmenopausal women. J Nutr 145, 187192.
39. Rissanen, TH, Voutilainen, S, Nyyssonen, KI et al. (2001) Low serum lycopene concentration is associated with an excess incidence of acute coronary events and stroke: the Kuopio Ischaemic Heart Disease Risk Factor Study. Br J Nutr 85, 749754.
40. Sesso, HD, Buring, JE, Norkus, EP et al. (2004) Plasma lycopene, other carotenoids, and retinol and the risk of cardiovascular disease in women. Am J Clin Nutr 79, 4753.
41. Yeo, HY, Kim, OY, Lim, HH et al. (2011) Association of serum lycopene and brachial-ankle pulse wave velocity with metabolic syndrome. Metabolism 60, 537543.
42. Karppi, J, Kurl, S, Ronkainen, K et al. (2013) Serum carotenoids reduce progression of early atherosclerosis in the carotid artery wall among eastern Finnish men. PLoS ONE 8, e64107.
43. Karppi, J, Laukkanen, JA, Sivenius, J et al. (2012) Serum lycopene decreases the risk of stroke in men. Neurology 79, 15401547.
44. Wang, Y, Chung, SJ, McCullough, ML et al. (2014) Dietary carotenoids are associated with cardiovascular disease risk biomarkers mediated by serum carotenoid concentrations. J Nutr 144, 10671074.
45. Ascherio, A, Rimm, EB, Hernan, MA et al. (1999) Relation of consumption of vitamin E, vitamin C, and carotenoids to risk for stroke among men in the United States. Ann Intern Med 130, 963970.
46. Hirvonen, T, Virtamo, J, Korhonen, P et al. (2000) Intake of flavonoids, carotenoids, vitamins C and E, and risk of stroke in male smokers. Stroke 31, 23012306.
47. Osganian, SK, Stampfer, MJ, Rimm, E et al. (2003) Dietary carotenoids and risk of coronary artery disease in women. Am J Clin Nutr 77, 13901399.
48. Tavani, A, Gallus, S, Negri, E et al. (2006) Dietary intake of carotenoids and retinol and the risk of acute myocardial infarction in Italy. Free Radic Res 40, 659664.
49. Li, X & Xu, J (2014) Dietary and circulating lycopene and stroke risk: a meta-analysis of prospective studies. Sci Rep 4, 5031.
50. Kelkel, M, Schumacher, M, Dicato, M et al. (2011) Antioxidant and anti-proliferative properties of lycopene. Free Radic Res 45, 925940.
51. Feitelson, MA, Arzumanyan, A, Kulathinal, RJ et al. (2015) Sustained proliferation in cancer: mechanisms and novel therapeutic targets. Semin Cancer Biol 35, S25S54.
52. Amir, H, Karas, M, Giat, J et al. (1999) Lycopene and 1,25-dihydroxyvitamin D3 cooperate in the inhibition of cell cycle progression and induction of differentiation in HL-60 leukemic cells. Nutr Cancer 33, 105112.
53. Gupta, P, Bansal, MP & Koul, A (2013) Evaluating the effect of lycopene from Lycopersicum esculentum on apoptosis during NDEA induced hepatocarcinogenesis. Biochem Biophys Res Commun 434, 479485.
54. Uppala, PT, Dissmore, T, Lau, BHS et al. (2013) Selective inhibition of cell proliferation by lycopene in MCF-7 breast cancer cells in vitro: a proteomic analysis. Phytother Res 27, 595601.
55. Agca, CA, Tuzcu, M, Gencoglu, H et al. (2012) Lycopene counteracts the hepatic response to 7,12 dimethylbenz[a]anthracene by altering the expression of Bax, Bcl-2, caspases, and oxidative stress biomarkers. Pharm Biol 50, 15131518.
56. Chalabi, N, Delort, L, Le Corre, L et al. (2006) Gene signature of breast cancer cell lines treated with lycopene. Pharmacogenomics 7, 663672.
57. Stahl, W, von Laar, J, Martin, HD et al. (2000) Stimulation of gap junctional communication: comparison of acyclo-retinoic acid and lycopene. Arch Biochem Biophys 373, 271274.
58. Palozza, P, Simone, RE, Catalano, A et al. (2011) Tomato lycopene and lung cancer prevention: from experimental to human studies. Cancers 3, 23332357.
59. Palozza, P, Simone, R, Catalano, A et al. (2012) Lycopene modulation of molecular targets affected by smoking exposure. Curr Cancer Drug Targets 12, 640657.
60. Chen, ML, Lin, YH, Yang, CM et al. (2012) Lycopene inhibits angiogenesis both in vitro and in vivo by inhibiting MMP-2/uPA system through VEGFR2-mediated PI3 K-Akt and ERK/p38 signaling pathways. Mol Nutr Food Res 56, 889899.
61. Huang, CS, Chuang, CH, Lo, TF et al. (2013) Antiangiogenic effects of lycopene through immunomodualtion of cytokine secretion in human peripheral blood mononuclear cells. J Nutr Biochem 24, 428434.
62. Lian, F & Wang, XD (2008) Enzymatic metabolites of lycopene induce Nrf2-mediated expression of phase II detoxifying/antioxidant enzymes in human bronchial epithelial cells. Int J Cancer 123, 12621268.
63. Sahin, K, Tuzcu, M, Sahin, N et al. (2010) Nrf2/HO-1signaling pathway may be the prime target for chemoprevention of cisplatin-induced nephrotoxicity by lycopene. Food Chem Toxicol 48, 26702674.
64. Linnewiel, K, Ernst, H, Caris-Veyrat, C et al. (2009) Structure activity relationship of carotenoid derivatives in activation of the electrophile/antioxidant response element transcription system. Free Radic Biol Med 47, 659667.
65. Herzog, A, Siler, U, Spitzer, V et al. (2005) Lycopene reduced gene expression of steroid targets and inflammatory markers in normal rat prostate. FASEB J 19, 272274.
66. Aydemir, G, Kasiri, Y, Birta, E et al. (2014) Lycopene-derived bioactive retinoic acid receptors/retinoid-X receptors-activating metabolites may be relevant for lycopene's anti-cancer potential. Mol Nutr Food Res 57, 739747.
67. Tan, HL, Moran, NE, Cichon, MJ et al. (2014) β-Carotene-9′,10′-oxygenase status modulates the impact of dietary tomato and lycopene on hepatic nuclear receptor-, stress-, and metabolism-related gene expression in mice. J Nutr 144, 43439.
68. Stahl, W & Sies, H (2012) Photoprotection by dietary carotenoids: concept, mechanisms, evidence and future development. Mol Nutr Food Res 56, 287295.
69. Aydemir, G, Kasiri, Y, Bartók, EM et al. (2016) Lycopene supplementation restores vitamin A deficiency in mice and possesses thereby partial pro-vitamin A activity transmitted via RAR-signaling. Mol Nutr Food Res. (Epublication ahead of print version).
70. Palozza, P, Parrone, N, Simone, RE et al. (2010) Lycopene in atherosclerosis prevention: an integrated scheme of the potential mechanisms of action from cell culture studies. Arch Biochem Biophys 504, 2633.
71. Tang, X, Yang, X, Peng, Y et al. (2009) Protective effects of lycopene against H2O2-induced oxidative injury and apoptosis in human endothelial cells. Cardiovasc Drugs Ther 23, 439448.
72. Hung, CF, Huang, TF, Chen, BH et al. (2008) Lycopene inhibits TNF-alpha-induced endothelial ICAM-1 expression and monocyte-endothelial adhesion. Eur J Pharmacol 586, 275282.
73. Hsiao, G, Wang, Y, Tzu, NH et al. (2005) Inhibitory effects of lycopene on in vitro platelet activation and in vivo prevention of thrombus formation. J Lab Clin Med 146, 216226.
74. Sawardekar, SB, Patel, TC & Uchil, D (2016) Comparative evaluation of antiplatelet effect of lycopene with aspirin and the effect of their combination on platelet aggregation: an in vitro study. Indian J Pharmacol 48, 2631.
75. Palozza, P, Simone, R, Catalano, A et al. (2011) Lycopene regulation of cholesterol synthesis and efflux in human macrophages. J Nutr Biochem 22, 971978.
76. Napolitano, M, De Pascale, C, Wheeler-Jones, et al. (2007) Effects of lycopene on the induction of foam cell formation by modified LDL. Am J Physiol Endocrinol Metab 293, E1820E1827.
77. Müller, L, Caris-veyrat, C, Lowe, G et al. (2015) Lycopene and its antioxidant role in the prevention of cardiovascular diseases – a critical review. Crit Rev Food Sci Nutr 56, 18681879.
78. Marcotorchino, J, Romier, B, Gouranton, E et al. (2012) Lycopene attenuates LPS-induced TNF-α secretion in macrophages and inflammatory markers in adipocytes exposed to macrophage-conditioned media. Mol Nutr Food Res 56, 725732.
79. Zou, J, Feng, D, Ling, WH et al. (2013) Lycopene suppresses proinflammatory response in lipopolysaccharide-stimulated macrophages by inhibiting ROS-induced trafficking of TLR4 to lipid raft-like domains. J Nutr Biochem 24, 11171122.
80. Lo, HM, Hung, CF, Tseng, YL et al. (2007) Lycopene binds PDGF-BB and inhibits PDGF-BB-induced intracellular signaling transduction pathway in rat smooth muscle cells. Biochem Pharmacol 74, 5463.
81. McDevitt, TM, Tchao, R, Harrison, EH et al. (2005) Carotenoids normally present in serum inhibit proliferation and induce differentiation of a human monocyte/macrophage cell line (U937). J Nutr 135, 160164.
82. Mills, L, Wilson, H & Thies, F (2012) Lycopene inhibits lymphocyte proliferation through mechanisms dependent on early cell activation. Mol Nutr Food Res 56, 10341042.
83. Ford, NA, Elsen, AC, Zuniga, K et al. (2011) Lycopene and apo-12′-lycopenal reduce cell proliferation and alter cell cycle progression in human prostate cancer cells. Nutr Cancer 63, 256263.
84. Gouranton, E, Thabuis, C, Riollet, C et al. (2011) Lycopene inhibits proinflammatory cytokine and chemokine expression in adipose tissue. J Nutr Biochem 22, 642648.
85. Tabrez, S, Al-Shali, KZ & Ahmad, S (2015) Lycopene powers the inhibition of glycation-induced diabetic nephropathy: a novel approach to halt the AGE-RAGE axis menace. Biofactors 41, 372381.
86. Stirban, A, Gawlowski, T & Roden, M (2014) Vascular effects of advanced glycation endproducts: clinical effects and molecular mechanisms. Mol Metab 3, 94108.
87. Mordente, A, Guantario, B, Meucci, E et al. Lycopene and cardiovascular diseases: an update. Curr Med Chem 18, 11461163.
88. Biddle, MJ, Lennie, TR, Bricker, GV et al. (2016) Lycopene dietary intervention: a pilot study in patients with heart failure. Cardiovasc Nurs 30, 205212.
89. Gajendragadkar, PR, Hubsch, A, Maki-Petaja, KM et al. (2014) Effects of oral lycopene supplementation on vascular function in patients with cardiovascular disease and healthy Volunteers: a randomised controlled trial. PLoS ONE 9, e99070.
90. Zou, ZY, Xu, XR, Lin, XM et al. (2014) Effects of lutein and lycopene on carotid intima–media thickness in Chinese subjects with subclinical atherosclerosis: a randomised, double-blind, placebo-controlled trial. Br J Nutr 111, 474480.
91. Naqvi, TZ & Lee, MS (2014) Carotid intima-media thickness and plaque in cardiovascular risk assessment. J Am Coll Cardiol Img 7, 10251038.
92. McEneny, J, Wade, L, Young, IS et al. (2013) Lycopene reduces inflammation and improves HDL functionality in moderately overweight middle aged individuals. J Nutr Biochem 24, 163168.


Cardiovascular benefits of lycopene: fantasy or reality?

  • Frank Thies (a1), Lynsey M. Mills (a1), Susan Moir (a1) and Lindsey F. Masson (a2)


Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed